Also known as: cannabis banking problem · Schedule I banking prohibition · cannabis financial access

Federal Cannabis Banking Restrictions (United States)

Why Schedule I status leaves cannabis businesses cash-heavy and unbanked despite state legalization.

Automated fact-check pass
9 cited sources
Published
Last reviewed
How this page was made

This article is general information, not legal advice. Laws change; check current rules with official sources or a lawyer.

↯ The honest take

Cannabis is Schedule I at the federal level, so any bank serving the industry technically handles proceeds of federal drug trafficking—even in states where sales are fully legal. The law doesn't explicitly ban this, but anti-money laundering and drug trafficking statutes create enough legal exposure that most major banks won't touch it. Small workarounds exist, but the real fix requires either federal legalization or a banking safe-harbor law. Rescheduling to Schedule III helps with taxes, not banking.

The core problem: Schedule I status and money laundering law

Cannabis remains Schedule I under the Controlled Substances Act. Strong evidence That classification means revenue from cannabis sales—even sales fully legal under state law—is considered proceeds of federal drug trafficking in the eyes of federal law. Under 18 U.S.C. §§1956–1957, any bank that knowingly handles such proceeds can face criminal liability, civil penalties, and the loss of its federal deposit insurance or charter. Strong evidence[1]

The cannabis banking problem is not that a single statute explicitly forbids banking cannabis. Rather, the existing framework of federal drug law, the Bank Secrecy Act, and anti-money laundering regulations creates legal exposure so significant that most federally regulated financial institutions decline to serve the industry. Strong evidence[1]

FinCEN guidance (2014) and the safe harbor that isn't

In February 2014, the Treasury Department's Financial Crimes Enforcement Network (FinCEN) issued guidance (FIN-2014-G001) describing how banks could serve marijuana-related businesses while meeting Bank Secrecy Act obligations. Strong evidence[2] The guidance explicitly did not legalize cannabis banking; it explained the reporting expectations if a bank chose to accept the regulatory and criminal risk.

Under the guidance, banks must conduct enhanced due diligence on cannabis clients and file Suspicious Activity Reports (SARs) categorized as 'Marijuana Limited' for routine state-legal activity, 'Marijuana Priority' if red flags suggest federal enforcement priorities are implicated, or 'Marijuana Termination' when ending the relationship. Strong evidence[2]

As of 2024, FinCEN reported several thousand depository institutions filing marijuana-related SARs. Strong evidence[3] However, the number actively banking the cannabis industry is substantially smaller; many institutions file SARs only because a client unexpectedly turned out to be cannabis-adjacent.

Practical consequences for cannabis businesses

The banking restriction cascades into several realities for state-licensed cannabis operators:

Limited bank account access. Many cannabis dispensaries and cultivators cannot open or maintain checking accounts at major national banks. Some work with state-chartered credit unions or small community banks that have built internal compliance programs; others operate largely in cash, which creates accounting, safety, and audit burdens. Strong evidence[4]

No credit card processing. Visa, Mastercard, American Express, and Discover prohibit cannabis transactions on their networks. Workarounds like 'cashless ATM' systems (which accept cash but process transactions as ATM withdrawals) have been targeted by card networks for misrepresenting transaction types. Several such systems were shut down between 2021 and 2023. Strong evidence[5]

Limited access to capital. SBA-backed loans are unavailable to plant-touching cannabis businesses. Most traditional lenders will not extend mortgages, equipment financing, or working capital loans to cannabis retailers or cultivators. Capital typically comes from private equity, specialized REITs, or private lenders at elevated rates.

Section 280E tax burden. Federal tax code Section 280E prohibits businesses 'trafficking' in Schedule I or II substances from deducting ordinary business expenses such as rent, payroll, marketing, and utilities. Strong evidence[6] This is a tax issue separate from banking, but it compounds financial strain by pushing effective federal tax rates substantially higher than typical businesses. See Section 280E of the Internal Revenue Code for details.

Legislative attempts: SAFE and SAFER Banking Acts

The Secure and Fair Enforcement (SAFE) Banking Act, first introduced in 2019, would prohibit federal regulators from penalizing banks for serving state-legal cannabis businesses. The House passed various versions seven times, but no version became law. Strong evidence[7]

The SAFER Banking Act (S.2860, 118th Congress) was reported favorably by the Senate Banking Committee in September 2023 with bipartisan support. Strong evidence[8] As of October 2026, it has not received a floor vote in the full Senate and is not law.

If enacted, SAFER would not legalize cannabis or change its federal Schedule I status. Instead, it would create a safe harbor protecting depository institutions and ancillary service providers (payment processors, accountants, insurers) from federal penalties for serving state-legal cannabis businesses. Strong evidence[8] In other words, SAFER addresses the banking symptom without resolving the underlying federal prohibition.

For a detailed history of legislative efforts, see SAFE Banking Act: Legislative History.

Rescheduling: the May 2024 DEA proposal

In May 2024, the U.S. Department of Justice submitted a proposed regulation to move cannabis from Schedule I to Schedule III of the Controlled Substances Act, following a recommendation by the Department of Health and Human Services. Strong evidence[9] The proposal entered a public comment period and administrative review as of that date. As of October 2026, no final rulemaking has been issued.

If rescheduling to Schedule III is finalized, it would:

In short, rescheduling is primarily a tax fix, not a banking fix. Full banking normalization requires either federal legalization or a SAFER-style safe harbor law.

What full federal legalization would change

If cannabis were removed from the Controlled Substances Act entirely (rather than merely rescheduled), federal money laundering statutes would no longer treat cannabis revenue as proceeds of drug trafficking, and the core legal barrier to banking would disappear. Banks could serve the industry with standard compliance frameworks applied to other regulated industries.

However, as of October 2026, no bill to legalize cannabis federally has passed either chamber of Congress. Some states have legalized adult-use cannabis, and 24 states have medical cannabis programs, but federal prohibition remains in effect.

This article is informational only and is not legal, tax, or financial advice. Federal cannabis policy and state law are both evolving. Any specific situation—opening a business bank account, structuring a cannabis business, accepting payments, or filing taxes—should be reviewed with a qualified attorney, accountant, or compliance officer licensed in the relevant jurisdiction.

Last verified: October 2026. Check the status of the SAFER Banking Act, any final DEA rescheduling rulemaking, and FinCEN guidance for updates after this date.

Sources

How this page was made

Generation history

Oct 30, 2026
Fact-check pass — raised 7 flags
Oct 30, 2026
Revision
May 16, 2026
Fact-check pass — raised 2 flags
May 16, 2026
Initial draft

Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.